CN101869692A - 一种姜黄素类物自微乳及其制备方法 - Google Patents
一种姜黄素类物自微乳及其制备方法 Download PDFInfo
- Publication number
- CN101869692A CN101869692A CN 201010214085 CN201010214085A CN101869692A CN 101869692 A CN101869692 A CN 101869692A CN 201010214085 CN201010214085 CN 201010214085 CN 201010214085 A CN201010214085 A CN 201010214085A CN 101869692 A CN101869692 A CN 101869692A
- Authority
- CN
- China
- Prior art keywords
- curcumin
- self
- microemulsion
- oil
- microemulsion according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 title claims abstract description 112
- 229940109262 curcumin Drugs 0.000 title claims abstract description 56
- 235000012754 curcumin Nutrition 0.000 title claims abstract description 56
- 239000004148 curcumin Substances 0.000 title claims abstract description 56
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 title claims abstract description 56
- 239000004530 micro-emulsion Substances 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000000593 microemulsion method Methods 0.000 title description 3
- 239000004094 surface-active agent Substances 0.000 claims abstract description 13
- 239000004064 cosurfactant Substances 0.000 claims abstract description 9
- 239000003921 oil Substances 0.000 claims description 18
- 235000019198 oils Nutrition 0.000 claims description 18
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 claims description 15
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 claims description 15
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 claims description 15
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 claims description 15
- -1 polyoxyethylene Polymers 0.000 claims description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical group O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 6
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims description 6
- 239000010685 fatty oil Substances 0.000 claims description 5
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 claims description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical class C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 2
- 150000002333 glycines Chemical class 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 19
- 229940079593 drug Drugs 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 210000000170 cell membrane Anatomy 0.000 abstract description 2
- 239000012528 membrane Substances 0.000 abstract description 2
- 229940126701 oral medication Drugs 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- 239000012071 phase Substances 0.000 description 5
- 238000012377 drug delivery Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 2
- 239000008389 polyethoxylated castor oil Substances 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 240000005629 Curcuma phaeocaulis Species 0.000 description 1
- 235000003391 Curcuma phaeocaulis Nutrition 0.000 description 1
- 241000963390 Curcuma wenyujin Species 0.000 description 1
- 235000003394 Curcuma wenyujin Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- JYTVKRNTTALBBZ-UHFFFAOYSA-N bis demethoxycurcumin Natural products C1=CC(O)=CC=C1C=CC(=O)CC(=O)C=CC1=CC=CC(O)=C1 JYTVKRNTTALBBZ-UHFFFAOYSA-N 0.000 description 1
- PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- YXAKCQIIROBKOP-UHFFFAOYSA-N di-p-hydroxycinnamoylmethane Natural products C=1C=C(O)C=CC=1C=CC(=O)C=C(O)C=CC1=CC=C(O)C=C1 YXAKCQIIROBKOP-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002356 laser light scattering Methods 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229940044519 poloxamer 188 Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102140855A CN101869692B (zh) | 2010-06-30 | 2010-06-30 | 一种姜黄素类物自微乳及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102140855A CN101869692B (zh) | 2010-06-30 | 2010-06-30 | 一种姜黄素类物自微乳及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101869692A true CN101869692A (zh) | 2010-10-27 |
CN101869692B CN101869692B (zh) | 2011-06-29 |
Family
ID=42994898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102140855A Expired - Fee Related CN101869692B (zh) | 2010-06-30 | 2010-06-30 | 一种姜黄素类物自微乳及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101869692B (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266287A (zh) * | 2011-08-01 | 2011-12-07 | 山东大学 | 叶酸受体介导的姜黄素自微乳结肠定位释药制剂 |
CN103285401A (zh) * | 2013-05-27 | 2013-09-11 | 沈阳药科大学 | 一种能提高难溶性药物溶解性和生物利用度的组合物 |
CN104324020A (zh) * | 2014-11-06 | 2015-02-04 | 江苏隆力奇生物科技股份有限公司 | 一种含有虾青素与白藜芦醇的自微乳颗粒制备方法 |
CN105123990A (zh) * | 2015-10-08 | 2015-12-09 | 河南工业大学 | 一种制备稳定型芝麻酚微乳液的方法 |
CN105535979A (zh) * | 2015-11-22 | 2016-05-04 | 李素华 | 一种提高难溶药物生物利用度的自微乳化载药***及其应用 |
CN106619588A (zh) * | 2016-12-29 | 2017-05-10 | 厦门金达威生物科技有限公司 | 一种含辅酶q10的自微乳型营养组合物、制备方法及用途 |
CN106667912A (zh) * | 2017-02-08 | 2017-05-17 | 何德海 | 一种姜黄素纳米乳液的制备方法 |
CN107028883A (zh) * | 2017-04-20 | 2017-08-11 | 东北农业大学 | 运载姜黄素纳米乳的制备方法 |
CN107308133A (zh) * | 2016-04-27 | 2017-11-03 | 周意 | 姜黄素药物制剂 |
CN109152358A (zh) * | 2016-04-01 | 2019-01-04 | 雷根斯堡大学 | 光敏剂分散体及其用途 |
CN109170899A (zh) * | 2018-10-23 | 2019-01-11 | 成都植宇生物科技有限公司 | 一种提高姜黄素溶解度的组合物、制备方法及应用 |
WO2019019091A1 (zh) * | 2017-07-27 | 2019-01-31 | 周意 | 姜黄素药物制剂 |
CN112206206A (zh) * | 2020-10-15 | 2021-01-12 | 复旦大学附属中山医院青浦分院 | 一种***给药的姜黄素微乳凝胶剂的制备方法和应用 |
US11007149B1 (en) * | 2019-11-18 | 2021-05-18 | I-Shou University | Pharmaceutical compositions and uses thereof |
CN112972368A (zh) * | 2021-04-19 | 2021-06-18 | 哈尔滨医科大学 | 一种促进肛肠术后创面愈合的药物组合物及其制备方法 |
-
2010
- 2010-06-30 CN CN2010102140855A patent/CN101869692B/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
《中国药房》 20080630 袁海建等 自微乳药物传递***及其在中药制剂研究中的应用 第456-459页 1-10 第19卷, 第6期 * |
《齐鲁药事》 20090228 李兆明灯 自微乳制剂的研究进展 第98-100页 1-10 第28卷, 第2期 * |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266287A (zh) * | 2011-08-01 | 2011-12-07 | 山东大学 | 叶酸受体介导的姜黄素自微乳结肠定位释药制剂 |
CN102266287B (zh) * | 2011-08-01 | 2012-09-26 | 山东大学 | 叶酸受体介导的姜黄素自微乳结肠定位释药制剂 |
CN103285401A (zh) * | 2013-05-27 | 2013-09-11 | 沈阳药科大学 | 一种能提高难溶性药物溶解性和生物利用度的组合物 |
CN104324020A (zh) * | 2014-11-06 | 2015-02-04 | 江苏隆力奇生物科技股份有限公司 | 一种含有虾青素与白藜芦醇的自微乳颗粒制备方法 |
CN105123990A (zh) * | 2015-10-08 | 2015-12-09 | 河南工业大学 | 一种制备稳定型芝麻酚微乳液的方法 |
CN105123990B (zh) * | 2015-10-08 | 2021-08-06 | 河南工业大学 | 一种制备稳定型芝麻酚微乳液的方法 |
CN105535979A (zh) * | 2015-11-22 | 2016-05-04 | 李素华 | 一种提高难溶药物生物利用度的自微乳化载药***及其应用 |
CN105535979B (zh) * | 2015-11-22 | 2019-06-25 | 李素华 | 一种提高难溶药物生物利用度的自微乳化载药***及其应用 |
CN109152358A (zh) * | 2016-04-01 | 2019-01-04 | 雷根斯堡大学 | 光敏剂分散体及其用途 |
EP3225112B1 (de) | 2016-04-01 | 2021-08-18 | TriOptoTec GmbH | Photosensibilisator-dispersion und verwendung derselben |
CN107308133A (zh) * | 2016-04-27 | 2017-11-03 | 周意 | 姜黄素药物制剂 |
CN106619588B (zh) * | 2016-12-29 | 2019-08-16 | 厦门金达威生物科技有限公司 | 一种含辅酶q10的自微乳型营养组合物、制备方法及用途 |
CN106619588A (zh) * | 2016-12-29 | 2017-05-10 | 厦门金达威生物科技有限公司 | 一种含辅酶q10的自微乳型营养组合物、制备方法及用途 |
CN106667912A (zh) * | 2017-02-08 | 2017-05-17 | 何德海 | 一种姜黄素纳米乳液的制备方法 |
CN107028883A (zh) * | 2017-04-20 | 2017-08-11 | 东北农业大学 | 运载姜黄素纳米乳的制备方法 |
WO2019019091A1 (zh) * | 2017-07-27 | 2019-01-31 | 周意 | 姜黄素药物制剂 |
CN109170899A (zh) * | 2018-10-23 | 2019-01-11 | 成都植宇生物科技有限公司 | 一种提高姜黄素溶解度的组合物、制备方法及应用 |
US11007149B1 (en) * | 2019-11-18 | 2021-05-18 | I-Shou University | Pharmaceutical compositions and uses thereof |
CN112206206A (zh) * | 2020-10-15 | 2021-01-12 | 复旦大学附属中山医院青浦分院 | 一种***给药的姜黄素微乳凝胶剂的制备方法和应用 |
CN112206206B (zh) * | 2020-10-15 | 2023-02-10 | 复旦大学附属中山医院青浦分院 | 一种***给药的姜黄素微乳凝胶剂的制备方法和应用 |
CN112972368A (zh) * | 2021-04-19 | 2021-06-18 | 哈尔滨医科大学 | 一种促进肛肠术后创面愈合的药物组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101869692B (zh) | 2011-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101869692B (zh) | 一种姜黄素类物自微乳及其制备方法 | |
Karataş et al. | Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol | |
Li et al. | Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability | |
Date et al. | Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery | |
Mishra et al. | Orally administered self-emulsifying drug delivery system in disease management: advancement and patents | |
JP5491724B2 (ja) | 生物学的利用能を向上した医薬組成物 | |
US8835509B2 (en) | Self emulsifying drug delivery system for a curcuminoid based composition | |
CN100463670C (zh) | 用于不溶于水的抗感冒药物口服给药的微乳浓缩液及其制备方法 | |
CN104337859B (zh) | 一种甘草黄酮自微乳组合物及其制备方法 | |
AU2014235733B2 (en) | Racecadotril lipid compositions | |
TW201114766A (en) | Pharmaceutical composition for a hepatitis C viral protease inhibitor | |
CN101019833A (zh) | 一种用作药物载体的药用油包油型非水微乳及其药物制剂 | |
CN107184549B (zh) | 一种尼达尼布自微乳制剂和其制成的软胶囊及制备方法 | |
RU2632441C2 (ru) | Липидные композиции рацекадотрила | |
TW201521719A (zh) | 含有脂質化合物、三酸甘油酯及界面活性劑之組成物與使用該組成物之方法 | |
CN108472253A (zh) | 塞来昔布的胃肠外组合物 | |
Djekic et al. | Design of block copolymer costabilized nonionic microemulsions and their in vitro and in vivo assessment as carriers for sustained regional delivery of ibuprofen via topical administration | |
Sindi et al. | Preparation and evaluation of protective effect of pumpkin seed oil based self nanoemulsifying oral delivery system against ibuprofen-induced peptic ulcer | |
CN107921017A (zh) | 使用卡多曲组合物进行治疗的方法 | |
EP1249231B1 (de) | Pharmazeutische Formulierungen enthaltend entzündungshemmende Wirkstoffe und deren Verwendung | |
Sahu et al. | Formulation strategies to improve the bioavailability of poorly absorbed drugs | |
CN101904815B (zh) | 一种布洛芬微乳制剂及制备方法 | |
CN102106866B (zh) | 一种药物组合物及其制备方法 | |
Hassan et al. | Enhanced bioavailability and pharmacokinetics parameters of Enalapril solid self nanoemulsifying oral dispersible tablet: Formulation, in vitro and in vivo evaluation | |
CN101700224A (zh) | 一种硫酸软骨素口服纳米乳的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG LUNUO ANIMAL PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: JIANG YUNHUA Effective date: 20111209 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20111209 Address after: South Development Zone 274200 Shandong city of Heze province Chengwu County Patentee after: Shandong Lunuo Animal Pharmaceutical Co., Ltd. Address before: South Development Zone 274200 Shandong city of Heze province Chengwu County lunuo pharmaceutical Patentee before: Jiang Yunhua |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20150630 |
|
EXPY | Termination of patent right or utility model |